leisure time -WSS

leisure time

author：leisure time 2025-09-27 16:47:35 - browse：1746

SAN DIEGO — After starting off the year with lower revenue projections than market analysts had hoped for, San Diego-based genomics giant Illumina lowered expectations again on Wednesday, forecasting annual growth of 1% compared to the previous year.

The market’s response was swift. Minutes after the company issued its press release, shares in Illumina dipped from $184.49 to below $172 during after-hours trading.

In its release, Illumina noted that it expects revenue from the company’s core business to be essentially the same this year compared to last, and that it expects revenue from Grail, the cancer diagnostics company that Illumina acquired for $8 billion in the fall of 2021, to remain in the range of $90 and $100 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

leisure time

WSS

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

After sickle

California man arrested in connection with serial murders of Mexican strip club workers

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Drinking water from half of US faucets contains PFAS: Study

Rare Northern Lights show in US this week: Where and how to see it

explore

leisure time

leisure time

Activists slam private health insurers over coverage restrictions

Trump seeks lengthy delay of classified docs trial, citing upcoming election

Medicare details structure of new drug price negotiation program

STAT letters to the editor on burnt

Supreme Court strikes down use of affirmative action

Drinking water from half of US faucets contains PFAS: Study

As demand for Covid shots wanes, Moderna seeks its next success

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

State Dept. review finds Biden bears some blame for Afghanistan failures

How corporate America is slashing DEI workers amid backlash to diversity programs

leisure time

The woman behind the Dana Farber

What causes an itch? Researchers may have solved the mystery

Spinal cord stimulation reduces pain in amputees, study finds

The woman behind the Dana Farber

Leukemia patients are helped by Syndax's new type of therapy

Titanic submersible: What a 'catastrophic implosion' means and what officials found

leisure time

leisure time

entertainment

hotspot